A research poster from the School of Underlying Conditions follows dormant medicine presentations on a national reimbursement schedule and asks why their sponsors keep them listed
A cohort of 611 dormant presentations on a national reimbursement schedule, and the sponsors who keep them listed
A medicine can stay on a reimbursement schedule for years after anyone last dispensed it, and a research poster from the School of Underlying Conditions sets out to learn how long, and on whose account. The Door Kept Open: Dormant Medicine Presentations on a National Reimbursement Schedule, 2012–2024 is the work of Dr Vigdis Emenike, Senior Lecturer, with Dr Anouk Mensah, Postdoctoral Fellow, and Dr Lindiwe Achterberg, Lecturer, both of the School of Emergent Priorities.
Bringing a schedule’s listings into conversation with its claims, the team follows 611 presentations from the month dispensing stopped through to delisting, a return to use, or neither, and sets that cohort beside conversations with the people whose annual returns keep each listing in place. Within five years, they find, most dormant listings do neither.
Fourteen people gave us an hour each to explain a form they file every year, and they were more generous about it than the form has ever been. Whatever this poster gets right is theirs.
— Dr Vigdis Emenike, Senior Lecturer, School of Underlying Conditions
For Dr Mensah, the poster is a welcome meeting point between two of the University’s schools. “We came to it from different ends of the building, and I suspect the most useful thing it does is leave us with better questions than we brought.”
The University counts the work as a fresh expression of its resolve to look beneath the surface of whatever it is handed, a schedule of medicines included.
The full poster is available from the University’s research repository under an open licence, doi:10.5555/slop.mob59p.